Categories: Health

Five-year Pharmacovigilance study by NTC confirms safety of fixed-dose eye drops for Post-cataract Surgery

MILAN, July 17, 2025 /PRNewswire/ — A recently published five-year pharmacovigilance study confirms the excellent safety profile of a fixed-dose combination eye drop containing an anti-inflammatory steroid and a quinolone antibiotic, developed by NTC, indicated for the prevention and treatment of inflammation and prevention of infection following cataract surgery in adults. The study was submitted when nearly 4 million patients across about 60 countries worldwide were treated with this drug.

- Advertisement -

Conducted by Italian researchers and supported by NTC, the study analyzed public safety data registered in the adrreports.eu portal, that collects safety reports from EudraVigilance, the European Medicines Agency’s official adverse drug reaction (ADR) database. The study identified only 53 ADRs occurred in 25 patients between 2020 and 2024. Key findings include:

- Advertisement -
  • 74% of ADRs were non-serious.
  • More than half were deemed unlikely to be related to the product.
  • The most frequently reported events were mild reactions involving the eye or skin—expected outcomes for a topically administered ophthalmic solution.
  • No case of endophthalmitis, a severe and rare infection that can occur following eye surgery, was reported.

“This is the first international pharmacovigilance study focused specifically on a fixed-dose eye drop combining an antibiotic and an anti-inflammatory steroid,” said Dr. Giorgio Ciprandi, senior author of the publication. “Its wide usage and favorable safety profile make of it a valuable option in the modern management of post-cataract patients’.”

The findings support the current recommendation of a short-term, seven-day treatment course, which improves patient adherence and limits the risk of side effects or antibiotic resistance.

- Advertisement -

The study also highlights the importance of pharmacovigilance in evaluating medicines after market approval. “This analysis confirms how continuous safety monitoring is essential to protect patients and support clinicians based on safety information collected from the spontaneous reporting,” said Alessandro Colombo, CSO in NTC.

- Advertisement -

Cataract surgery remains the most common ophthalmic procedure worldwide, and post-operative management is critical to ensure optimal recovery. Since its approval in 2020, this innovative combination has provided patients with a simplified one-week treatment regimen that reduces unnecessary exposure to antibiotics and minimizes the risks associated with prolonged steroid use.

Thanks to its consistent safety profile, the product has received marketing authorization renewal from European regulatory authorities.

- Advertisement -

About the Study
The study, titled “Pharmacovigilance on dexamethasone 1mg/mL + levofloxacin 5 mg/mL eye drops, solution: a five-year registry.”, was conducted by experts in ophthalmology and drug safety.

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/five-year-pharmacovigilance-study-by-ntc-confirms-safety-of-fixed-dose-eye-drops-for-post-cataract-surgery-302505372.html

PRNW Agency

Recent Posts

C3 AI Fiscal First Quarter 2026 Preliminary Financial Results

REDWOOD CITY, Calif.--(BUSINESS WIRE)--C3.ai, Inc. (“C3 AI,” “C3,” or the “Company”) (NYSE: AI), the Enterprise…

3 hours ago

Scott+Scott, Robins Kaplan, Hausfeld Reach Agreement with Greystar for Significant Monetary Relief and Important Business Reforms

SAN DIEGO--(BUSINESS WIRE)--The law firms of Scott+Scott, Robins Kaplan, and Hausfeld have reached an agreement…

3 hours ago

CJ 4DPLEX and Nu Metro Cinemas Strengthen Partnership with First-Ever SCREENX in South Africa

Durban, Nu Metro's New Location in South Africa, Will Feature the 270-Degree Panoramic SCREENX Auditorium…

8 hours ago

ViewSonic Opens Global Entries for the 6th ColorPro Awards: FLOW

Inviting Creators Worldwide to Capture the Rhythm of Creativity BREA, Calif., Aug. 6, 2025 /PRNewswire/ -- ViewSonic…

8 hours ago

Bayes Market Secures Strategic Investment to Lead the Prediction Market Revolution

HONG KONG, Aug. 6, 2025 /PRNewswire/ -- Bayes Labs team announces that Bayes Market, the prediction…

10 hours ago

Thailand’s Government Reaffirms Commitment to Strengthen Competitiveness in Dialogue With 30 Global Investors

BANGKOK, Aug. 6, 2025 /PRNewswire/ -- Thailand's Acting Prime Minister Mr. Phumtham Wechayachai today welcomed senior…

10 hours ago